Roots Analysis has done a detailed study on “Novel Vaccine Delivery Devices Market, 2019-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html
Key Market Insights
- Over 130 novel vaccine delivery devices, including marketed / under development products, are being investigated for the delivery of both liquid and solid formulations for vaccines
- The market landscape is fragmented, featuring both new entrants (small companies) and established players (mid-large sized enterprises); the US is currently considered to be the hub for vaccine delivery focused firms
- A myriad of invasive and non-invasive delivery devices based on different routes of administrations are under evaluation; majority of them are in clinical stages of development
- In order to achieve an edge over competing players, delivery device developers in this market are increasingly focusing on the integration of advanced features in their respective products / offerings
- An evaluation of 490+ marketed and pipeline products revealed that several vaccine candidates are likely to be considered for delivery via novel vaccine delivery device in the near future
- An increasing interest in the field is also reflected in the partnership activity, deals inked in the recent past were focused on a diverse range of devices, and involved both international and indigenous stakeholders
- The benefits of the novel vaccine deliver devices presently outweigh the challenges related to their development and sales; the growing optimism in this domain is evident in the opinions of industry veterans
- The future opportunity for novel vaccine delivery devices is expected to be distributed across various product types, routes of administration and key geographical regions
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com
Table of Contents
- PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines - EXECUTIVE SUMMARY
- INTRODUCTION
3.1. An Overview of Vaccines
3.1.1. Classification of Vaccines
3.1.1.1. Live, Attenuated Vaccines
3.1.1.2. Inactivated Vaccines
3.1.1.3. Subunit Vaccines
3.1.1.4. Toxoid Vaccines
3.1.1.5. DNA Vaccines
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis